Largest biotech by net assets

Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.

Gilead Sciences leads the 24 biotech ranked by net assets, at SAR 85.2B, ahead of BioNTech (SAR 80B) and Biogen (SAR 68.5B). Figures as of 18 Nov 2026, 14:28 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
24
First
Gilead SciencesSAR 85.2B
Median
SAR 7.6B
Combined market value
SAR 3.19T
Countries
5

Market values as of .

Largest biotech by net assets
#CompanyNet assets ↓Market capPriceToday1 yearPrice, 30 daysCountry
1Gilead SciencesGILD · Health CareSAR 85.2BSAR 792.1BSAR 638.65 1.60% up 33% up United States
2BioNTechBNTX · Health CareSAR 80BSAR 78.9BSAR 318.31 0.47% down 16% down Germany
3BiogenBIIB · Health CareSAR 68.5BSAR 139.1BSAR 940.71 0.34% down 49% up United States
4AmgenAMGN · Health CareSAR 32.5BSAR 929.1BSAR 1,717.70 0.95% down 34% up United States
5ModernaMRNA · Health CareSAR 32.4BSAR 313.9BSAR 775.71 3.93% down 755% up United States
6argenxARGX · Health CareSAR 27.5BSAR 223.5BSAR 3,554.15 0.36% down 4% up Belgium
7QiagenQGEN · Health CareSAR 14.2BSAR 38.5BSAR 186.61 0.12% down 12% up Netherlands
8Neurocrine BiosciencesNBIX · Health CareSAR 12.2BSAR 63BSAR 622.37 0.37% up 20% up United States
9VaxcytePCVX · Health CareSAR 10.1BSAR 35.3BSAR 222.81 3.59% down 22% up United States
10ExelixisEXEL · Health CareSAR 8.1BSAR 62.7BSAR 256.94 2.09% up 63% up United States
11Bio-TechneTECH · Health CareSAR 7.9BSAR 42.8BSAR 272.44 0.22% down 26% up United States
12RepligenRGEN · Health CareSAR 7.9BSAR 38.9BSAR 608.34 0.37% down 5% up United States
13CRISPR TherapeuticsCRSP · Health CareSAR 7.2BSAR 14.6BSAR 150.60 0.54% down 21% down Switzerland
14Revolution MedicinesRVMD · Health CareSAR 6.1BSAR 132BSAR 610.25 2.50% down 131% up United States
15Kymera TherapeuticsKYMR · Health CareSAR 5.9BSAR 38.9BSAR 455.82 3.44% down 87% up United States
16Krystal BiotechKRYS · Health CareSAR 4.6BSAR 33.2BSAR 1,119.86 0.22% up 46% up United States
17ImmunovantIMVT · Health CareSAR 3.2BSAR 25.8BSAR 124.57 0.21% down 43% up United States
18CG OncologyCGON · Health CareSAR 2.8BSAR 26.4BSAR 296.10 6.89% down 85% up United States
19Twist BioscienceTWST · Health CareSAR 1.8BSAR 28.6BSAR 420.11 6.63% up 340% up United States
20Scholar Rock HoldingSRRK · Health CareSAR 920.8MSAR 20.6BSAR 169.10 1.21% up 14% up United States
21Adaptive BiotechnologiesADPT · Health CareSAR 820.7MSAR 17.3BSAR 106.87 2.22% up 88% up United States
22Kodiak SciencesKOD · Health CareSAR 590.3MSAR 23.7BSAR 363.10 3.90% down 396% up United States
23Halozyme TherapeuticsHALO · Health CareSAR 183.1MSAR 41BSAR 359.98 0.55% down 37% up United States
24ImmunityBioIBRX · Health Care-SAR 1.9BSAR 25BSAR 23.48 4.68% up 193% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 3.7510 SAR).

Questions and answers

Which biotech rank first by net assets?

Gilead Sciences (SAR 85.2B), BioNTech (SAR 80B) and Biogen (SAR 68.5B) are the top three of the 24 biotech ranked by net assets as of 18 Nov 2026, 14:28 UTC.

How many biotech are in this ranking?

24 are ranked by net assets.

What are these biotech worth together?

The 24 biotech ranked by net assets have a combined market value of SAR 3.19T as of 18 Nov 2026, 14:28 UTC.

What does ranking by net assets measure?

Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.

Cite this page

Funkfolio, “Largest biotech by net assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=net-assets

Underlying data: Yahoo Finance; SEC EDGAR.